
TWST Stock Forecast & Price Target
TWST Analyst Ratings
Bulls say
Twist Bioscience is well positioned in the synthetic biology industry with its disruptive DNA synthesis platform. The company's strong customer commentary and a multiple growth drivers, including the increasing demand for real-world DNA validation and growth in AI-driven orders and drug discovery, make it a standout in the life science tools sector. Additionally, the company's focus on cost efficiency and potential for significant gross margin expansion through its Factory of the Future facility provide a clear path to profitability, further supporting its positive outlook.
Bears say
Twist Bioscience is a highly innovative synthetic biology company employing a proprietary semiconductor-based DNA synthesis platform to industrialize the engineering of biology, with a significant footprint in the fast-growing next-generation sequencing (NGS) market. While the company has a unique and disruptive technology and a strong growth trajectory, there are potential risks to their long-term success, including increased competition, market share erosion, and difficulty penetrating established markets. Furthermore, despite Twist's strong financial performance and impressive outlook, their reliance on AI-driven demand may also pose a risk to future growth potential.
This aggregate rating is based on analysts' research of Twist Bioscience Corp and is not a guaranteed prediction by Public.com or investment advice.
TWST Analyst Forecast & Price Prediction
Start investing in TWST
Order type
Buy in
Order amount
Est. shares
0 shares